Clinical Trials Directory

Trials / Completed

CompletedNCT03548974

Internet-based MOTOmed Exercise to Reduce Spasticity and Improve Physical Function in Persons With Multiple Sclerosis

Internet-based Physical Activity Promotion Using the MOTOmed Movement Trainer to Reduce Spasticity and Improve Physical Function in Moderately to Severely Affected Persons With Multiple Sclerosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
57 (actual)
Sponsor
University of Erlangen-Nürnberg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In an RCT, the effect of the MOTOmed movement trainer (Reck, Germany) on spasticity and physical function in pwMS with EDSS score between 4,5 and 7 is investigated. All subjects exercise at home and are supervised and supported by an exercise therapist via an online platform. We compare the effect of a 12 week passive, motor-driven movement therapy (VG1) to an intermittent active and passive training (VG2). After 12 weeks, VG1 continues with an active training including strengthening exercises for another 12 weeks. VG2 does not receive any intervention in the second study phase.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTreatment group 1The ms-intakt/MOTOmed-intervention is a home-based program using the MOTOmed movement trainer: 12 week passive, motor-driven movement therapy followed by 12 weeks of intermittent active and passive training after the 3month assessment. Training intensity was regulated by the participant's subjective, perceived exertion, which was rated between 6 and 20 on the BORG Scale. Therapists aimed at eliciting a BORG Feedback of between 10 (fairly light) and 15 (hard). The exercise training was home-based and supervised via the internet.
BEHAVIORALTreatment group 2The subjects assigned to interventiongroup2 started with 12 weeks intermittent active and passive training followed by 12 weeks of no intervention (Wash out phase)

Timeline

Start date
2015-01-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2018-06-07
Last updated
2018-06-07

Source: ClinicalTrials.gov record NCT03548974. Inclusion in this directory is not an endorsement.